Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Rodeberg

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Pediatric Blood & Cancer|August 11, 2020
Surgical management of extremity rhabdomyosarcoma: A consensus opinion from the Children's Oncology Group, the European Pediatric Soft-Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom StudiengruppeCarol D Morris, Per-Ulf Tunn, David A Rodeberg, et al.
Pediatric Blood & Cancer|February 9, 2005
Long-term medical effects of childhood and adolescent rhabdomyosarcoma: a report from the childhood cancer survivor studyJudith A Punyko, Ann C Mertens, James G Gurney, et al.
International Journal of Cancer|November 25, 2014
Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma CommitteeDavid A Rodeberg, Moody D Wharam, Elizabeth R Lyden, et al.
Pediatric Blood & Cancer|August 8, 2020
Local treatment of rhabdomyosarcoma of the female genital tract: Expert consensus from the Children's Oncology Group, the European Soft-Tissue Sarcoma Group, and the Cooperative Weichteilsarkom StudiengruppeTimothy B Lautz, Helene Martelli, Joerg Fuchs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2019
Randomized Phase II Trial of Bevacizumab or Temsirolimus in Combination With Chemotherapy for First Relapse Rhabdomyosarcoma: A Report From the Children's Oncology GroupLeo Mascarenhas, Yueh-Yun Chi, Pooja Hingorani, et al.
Journal of Pediatric Surgery|November 14, 2019
Precision oncology: A primer for pediatric surgeons from the APSA cancer committeeCourtney J Harris, Alicia M Waters, Elisabeth T Tracy, et al.
Cancer|October 20, 2020
Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children's Oncology GroupTimothy B Lautz, Yueh-Yun Chi, Minjie Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2013
Histologic and clinical characteristics can guide staging evaluations for children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma CommitteeAaron R Weiss, Elizabeth R Lyden, James R Anderson, et al.
Journal of Pediatric Surgery|July 18, 2020
Update on pediatric rhabdomyosarcoma: A report from the APSA Cancer CommitteeDaniel S Rhee, David A Rodeberg, Reto M Baertschiger, et al.
Cancer|June 8, 2019
Increased local failure for patients with intermediate-risk rhabdomyosarcoma on ARST0531: A report from the Children's Oncology GroupDana L Casey, Yueh-Yun Chi, Sarah S Donaldson, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Pediatric Blood & Cancer|August 11, 2020
Surgical management of extremity rhabdomyosarcoma: A consensus opinion from the Children's Oncology Group, the European Pediatric Soft-Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom StudiengruppeCarol D Morris, Per-Ulf Tunn, David A Rodeberg, et al.
Pediatric Blood & Cancer|February 9, 2005
Long-term medical effects of childhood and adolescent rhabdomyosarcoma: a report from the childhood cancer survivor studyJudith A Punyko, Ann C Mertens, James G Gurney, et al.
International Journal of Cancer|November 25, 2014
Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma CommitteeDavid A Rodeberg, Moody D Wharam, Elizabeth R Lyden, et al.
Pediatric Blood & Cancer|August 8, 2020
Local treatment of rhabdomyosarcoma of the female genital tract: Expert consensus from the Children's Oncology Group, the European Soft-Tissue Sarcoma Group, and the Cooperative Weichteilsarkom StudiengruppeTimothy B Lautz, Helene Martelli, Joerg Fuchs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2019
Randomized Phase II Trial of Bevacizumab or Temsirolimus in Combination With Chemotherapy for First Relapse Rhabdomyosarcoma: A Report From the Children's Oncology GroupLeo Mascarenhas, Yueh-Yun Chi, Pooja Hingorani, et al.
Journal of Pediatric Surgery|November 14, 2019
Precision oncology: A primer for pediatric surgeons from the APSA cancer committeeCourtney J Harris, Alicia M Waters, Elisabeth T Tracy, et al.
Cancer|October 20, 2020
Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children's Oncology GroupTimothy B Lautz, Yueh-Yun Chi, Minjie Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2013
Histologic and clinical characteristics can guide staging evaluations for children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma CommitteeAaron R Weiss, Elizabeth R Lyden, James R Anderson, et al.
Journal of Pediatric Surgery|July 18, 2020
Update on pediatric rhabdomyosarcoma: A report from the APSA Cancer CommitteeDaniel S Rhee, David A Rodeberg, Reto M Baertschiger, et al.
Cancer|June 8, 2019
Increased local failure for patients with intermediate-risk rhabdomyosarcoma on ARST0531: A report from the Children's Oncology GroupDana L Casey, Yueh-Yun Chi, Sarah S Donaldson, et al.
Pageof 7